Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Drug delivery technologies company Banner Pharmacaps, a subsidiary of Sobel NV, has announced that its Soflet Gelcaps can offer increased protection against drug counterfeiting and tampering when used with radio frequency identification devices.
Subscribe to our email newsletter
Soflet Gelcaps is a unique, patented enrobing technology, originated by Banner, that provides tamper-evident security for valuable brand franchises at a cost of only pennies per tablet. The technology provides security backup due to the complex manufacturing process that puts a tightly adhering gelatin film around the tablet core, producing a tamper-evident, and tamper-resistant shield.
“Our motivation in creating Soflet Gelcaps was to produce an easier-to-swallow coating that also provided good protection for the active ingredients,” said Roger Gordon, president and CEO of Banner. “We’re gratified that our coating can also serve as added security against counterfeiting and adulteration at a very modest cost.”
An FDA task force report issued in October 2003 calls for implementation of track-and-trace technologies like radio frequency identification devices (RFID), and suggests that redundant security measures are more effective than single measures.